Rosiglitazone

peroxisome proliferator-activated receptor gamma ; Rattus norvegicus







337 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
301 16307220 Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia. 2005 Nov 5
302 18220608 Intracellular fatty acid metabolism in skeletal muscle and insulin resistance. 2005 Aug 1
303 14593089 Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats. 2004 Feb 2
304 14709329 Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation. 2004 Jan 1 7
305 15007093 Lysophosphatidic acid induces neointima formation through PPARgamma activation. 2004 Mar 15 2
306 15191358 PPARgamma inhibits GH synthesis and secretion and increases apoptosis of pituitary GH-secreting adenomas. 2004 Jun 1
307 15237101 Expression and functional activity of PPARgamma in pancreatic beta cells. 2004 Aug 2
308 15256367 Actions of PPARgamma agonism on adipose tissue remodeling, insulin sensitivity, and lipemia in absence of glucocorticoids. 2004 Nov 1
309 15371745 Rosiglitazone improves contextual fear conditioning in aged rats. 2004 Oct 5 1
310 15549648 Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone). 2004 Oct 1
311 15556153 Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. 2004 Nov 28 2
312 12414803 Rosiglitazone and retinoic acid induce uncoupling protein-1 (UCP-1) in a p38 mitogen-activated protein kinase-dependent manner in fetal primary brown adipocytes. 2003 Jan 3 2
313 12475752 Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats. 2003 Apr 1
314 12556350 PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. 2003 Mar 1
315 12694805 A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth. 2003 Apr 18 9
316 12795656 Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats. 2003 Jul 1
317 12798436 The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction. 2003 Jun 1 2
318 12821652 The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation. 2003 Sep 26 2
319 12840602 Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury. 2003 Jul-Aug 1
320 12897060 PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist. 2003 Oct 5
321 12933694 Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes. 2003 Sep 1
322 12970094 Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. 2003 Sep 4
323 14740079 Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats. 2003 Dec 1
324 11978649 Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury. 2002 May 1
325 12083418 Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia. 2002 Jun 1
326 12087064 Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. 2002 Jul 1
327 11230363 Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells. 2001 Feb 1
328 11319222 Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones. 2001 Jul 6 1
329 11412280 Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat. 2001 Jun 1
330 11598137 Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells. 2001 Dec 14 2
331 11707695 Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration. 2001 Dec 2
332 11714655 In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. 2001 Nov 20 1
333 11745411 PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells. 2001 Nov 1 1
334 10873645 Synergistic activation of UCP-3 expression in cultured fetal rat brown adipocytes by PPARalpha and PPARgamma ligands. 2000 Jul 5 1
335 11225966 Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat. 2000 Dec 2
336 10529360 PPARalpha activation by Wy 14643 induces transactivation of the rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPARgamma-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes. 1999 Oct 22 1
337 9703335 Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. 1998 Aug 3